tradit
diagnost
tool
positivesens
singl
strand
rna
ssrna
virus
viru
neutral
test
viru
isol
regard
gold
standard
serolog
virolog
investig
also
time
consum
labor
intens
elisarel
assay
rel
rapid
wide
use
due
low
sensit
although
nucleotidebas
technolog
pcr
real
time
pcr
sensit
rapid
expens
well
vulner
fals
posit
result
aris
contamin
sampl
sourc
contamin
furthermor
anoth
disadvantag
elisabas
nucleotidebas
assay
neither
differenti
infecti
noninfecti
viru
therefor
rapid
specif
live
cell
report
system
pathogen
may
play
import
role
monitor
infecti
diseas
viru
research
develop
high
throughput
technolog
genet
screen
enabl
widespread
use
live
cellbas
assay
rapid
sampl
detect
screen
assay
evalu
antivir
agent
vaccin
pathogenesi
research
past
decad
review
provid
uptod
examin
gener
principl
applic
live
cell
report
system
fig
first
type
classic
report
system
base
live
recombin
viru
carri
report
protein
enhanc
green
fluoresc
protein
egfp
firefli
luciferas
fluc
secret
alkalin
phosphatas
fig
tabl
gener
recombin
viru
recombin
plasmid
construct
fuse
report
protein
viral
structur
protein
insert
code
sequenc
report
protein
behind
terminu
viral
structur
protein
gene
subsequ
recombin
viru
rescu
cell
transfect
transcript
produc
recombin
plasmid
similarli
base
infecti
complementari
dna
cdna
clone
dengu
viru
denv
recombin
denv
gener
luciferas
develop
engin
luciferas
gene
capsidcod
region
infecti
cdna
clone
studi
indic
report
system
use
measur
neutral
antibodydepend
enhanc
activ
classic
swine
fever
viru
csfv
stabli
express
luciferas
develop
insert
luciferas
gene
npro
gene
csfv
report
viru
enabl
sensit
conveni
detect
npro
protein
express
viral
replic
luciferas
assay
tradit
method
csfv
npro
detect
earli
h
post
infect
addit
two
semliki
forest
viru
sfv
construct
develop
insert
egfp
gene
renilla
luciferas
rluc
gene
viru
replicas
open
read
frame
flank
proteaserecognit
site
subsequ
infecti
sfv
express
detect
egfp
rluc
upon
infect
obtain
electropor
vitro
transcript
construct
anoth
strategi
classic
report
system
util
report
viru
particl
rvp
fig
rvp
type
viruslik
particl
vlp
compos
viral
structur
protein
selfrepl
replicon
rna
contain
report
gene
obtain
rvp
west
nile
viru
wnv
red
fluoresc
protein
gene
insert
wnv
rna
genom
replac
c
prm
e
protein
gene
gener
wnv
replicon
rna
subsequ
replicon
rna
transcrib
vitro
cotransfect
cell
two
dna
express
plasmid
viral
c
prme
protein
final
rvp
gener
new
protocol
prepar
rvp
replicon
rna
stabli
transfect
express
cell
two
plasmid
dna
express
plasmid
viral
c
prme
protein
cotransfect
cell
packag
replicon
rna
rvp
rvp
system
rvp
capabl
one
round
infect
suscept
cell
due
lack
structur
protein
gene
within
replicon
rna
howev
rvp
use
tool
studi
viral
genom
packag
cellular
factor
although
recombin
virus
infecti
virus
express
fluoresc
protein
tend
attenu
due
modif
genom
furthermor
mani
virus
extrem
virul
pathogen
middl
east
respiratori
syndrom
mer
sever
acut
respiratori
syndrom
coronaviru
sarscov
csfv
handl
special
laboratori
highest
biosafeti
level
overcom
limit
viral
subgenom
replicon
develop
proven
valuabl
measur
replic
kinet
replicon
fig
tabl
selfrepl
subgenom
replicon
genet
engin
viral
rna
molecul
shorter
fulllength
viral
genom
capabl
replic
incap
produc
virion
howev
packag
viral
particl
viral
coat
protein
provid
flavivirida
virus
csfv
two
selfrepl
rna
replicon
produc
replac
code
region
c
csfv
rluc
sequenc
code
region
c
sequenc
subsequ
translat
replic
replicon
rna
could
follow
accumul
luciferas
protein
well
detect
csfv
nonstructur
protein
ns
product
within
cell
similarli
two
kind
replicon
construct
wnv
one
replicon
encod
rluc
follow
intern
ribosom
entri
site
ire
element
capindepend
translat
open
read
frame
encompass
carboxytermin
sequenc
e
protein
protein
second
replicon
contain
luciferas
gene
foot
mouth
diseas
viru
neomycin
phosphotransferas
gene
allow
establish
stabl
mammalian
cell
line
express
rluc
protein
presenc
neomycin
analog
stabl
repliconexpress
cell
line
use
cellbas
screen
determin
effect
concentr
valu
antivir
compound
inhibit
wnv
replic
hepat
c
viru
hcv
lohmann
colleagu
establish
effici
cell
cultur
system
base
self
replic
engin
hcv
replicon
first
one
develop
cotransfect
vitrotranscrib
hcv
bicistron
replicon
rna
analog
mutant
carri
infram
delet
polymeras
activ
site
bicistron
replicon
compos
hcvire
neomycin
phosphotransferas
neo
gene
ire
encephalomyocard
viru
direct
translat
hcv
sequenc
region
utr
howev
replicon
focus
hcv
genotyp
effici
rna
replic
system
genotyp
genotyp
establish
furthermor
construct
tricistron
hcv
replicon
two
sequenti
iress
use
initi
translat
human
rluc
hcv
nonstructur
gene
along
authent
hcv
ire
initi
translat
neomycin
resist
gene
result
demonstr
tricistron
replicon
effici
evalu
hcv
infect
chikungunya
viru
chikv
replicon
construct
replac
structur
gene
viru
gaussia
luciferas
gluc
gene
two
helper
plasmid
contain
chikv
replic
signal
subgenom
promot
follow
either
capsid
gene
remain
structur
protein
construct
express
either
chikv
capsid
protein
envelop
protein
respect
cotransfect
replicon
helper
plasmid
viru
replicon
particl
vrp
could
effici
produc
positivesens
singl
strand
rna
viru
genom
encod
larg
polyprotein
precursor
cleav
structur
nonstructur
protein
action
cellular
viralencod
proteas
viru
genom
specif
proteas
recogn
specif
cleavag
site
polyprotein
moreov
cleavag
polyprotein
viral
proteas
absolut
requir
assembl
viral
replicas
indic
cleavag
polyprotein
depend
particular
viru
infect
viral
proteas
cleavag
site
sequenc
ideal
element
report
viral
infect
past
decad
larg
number
virusspecif
proteas
cleavag
site
identifi
use
design
engin
report
cell
specif
viru
infect
fig
tabl
viral
proteas
proteas
hcv
becam
attract
target
develop
report
system
hcv
infect
one
strategi
involv
fusion
egfp
secret
alkalin
phosphatas
seap
proteas
recognit
sequenc
hcv
infect
fuse
protein
cleav
proteas
seap
secret
extracellular
cultur
medium
strategi
made
possibl
monitor
activ
replic
hcv
genom
rna
insid
mammalian
cell
measur
seap
level
cultur
medium
anoth
strategi
recombin
caspas
use
specif
substrat
proteas
endogen
cleavag
site
procaspas
molecul
substitut
decapeptid
specif
proteas
cleavag
hcv
infect
activ
depend
specif
cleavag
proteas
result
apoptosi
hcvinfect
cell
addit
tanaka
colleagu
establish
indic
cell
system
transcript
factor
human
immunodefici
viru
type
tat
protein
util
chimer
tat
transcript
factor
contain
hcv
cleavag
sequenc
mitochondriaresid
manipul
local
endoplasm
reticulum
upon
infect
hcv
transcript
factor
effici
cleav
hcv
proteas
migrat
nucleu
activ
report
gene
tandem
promot
anoth
proteas
proteas
csfv
previous
develop
darktobright
report
cell
csfv
infect
assay
base
novel
report
cell
stabli
express
egfp
fuse
infram
quench
peptid
via
special
recognit
sequenc
csfv
proteas
without
csfv
infect
although
egfp
express
report
cell
chromophor
matur
egfp
report
cell
inhibit
ctermin
quench
peptid
egfp
howev
cell
infect
csfv
recognit
sequenc
csfv
proteas
specif
cleav
proteas
quench
peptid
releas
protein
subsequ
egfp
undergo
conform
rearrang
allow
matur
chromophor
gain
fluoresc
make
cell
darktobright
report
csfv
infect
similarli
denvspecif
report
system
creat
util
viral
proteas
cleavag
site
result
nuclear
local
gfp
denvinfect
cell
report
system
base
plasmidcontain
proteas
cleavag
site
genom
tag
nl
nuclear
local
sequenc
egfp
denv
rvp
infect
egfp
transfer
cytoplasm
nucleu
report
system
shown
effect
detect
infect
cell
four
denv
serotyp
well
lowpassag
viral
strain
furthermor
system
also
valid
detect
vlp
vrp
rvp
even
construct
produc
proteas
rna
positivesens
singl
strand
rna
viru
genom
also
encod
rnadepend
rna
polymeras
rdrp
catalyz
synthesi
viral
rna
consid
anoth
target
viru
detect
erad
gener
report
gene
regul
specif
viral
rdrp
defect
replicon
fig
without
viru
infect
replicon
fail
express
report
gene
effici
howev
cell
infect
specif
viru
viral
rdrp
provid
viru
defect
replicon
activ
result
highlevel
express
report
gene
could
easili
examin
alphavirus
sindbi
viru
sinv
stabl
cell
line
contain
luciferas
gene
control
sinv
subgenom
rna
promot
establish
cell
line
express
high
level
luciferas
activ
infect
sinv
provid
sensit
assay
titer
viru
moreov
speciesspecif
insect
cellbas
system
detect
wildtyp
sinv
infect
develop
produc
sinv
minigenom
contain
viru
induc
promot
fluoresc
gene
viru
infect
fluoresc
gene
special
induc
express
cell
anoth
system
replicondefect
plasmid
deriv
sinv
construct
replac
structur
gene
sinv
report
gene
delet
bp
ns
gene
viru
upon
infect
viru
viral
compon
induc
express
report
gene
cell
transfect
replicondefect
plasmid
anoth
replicasesensor
report
system
base
bicistron
report
plasmid
design
fluc
utrrluc
construct
compris
fluc
gene
rluc
gene
revers
orient
flank
neg
strand
hcv
utr
fluc
rluc
protein
regul
host
polymeras
function
polymeras
respect
bicistron
plasmid
stabli
transfect
babi
hamster
cell
gener
report
cell
line
use
simultan
measur
cellular
toxic
intracellular
rdrp
activ
system
specif
hcv
rdrp
activ
assay
inhibitor
evalu
cell
base
report
system
combin
genet
proteom
approach
includ
rna
interfer
microarray
twodimension
gel
electrophoresi
coupl
malditoftof
identif
shown
promis
strategi
research
viru
infect
pathogenesi
gener
recombin
viru
rvp
mimic
viru
life
cycl
report
protein
serv
indirect
readout
thu
function
viral
protein
interact
protein
elucid
measur
report
protein
activ
furthermor
translat
replic
subgenom
replicon
rna
could
follow
accumul
luciferas
protein
cell
use
report
system
demonstr
csfv
core
protein
regul
csfv
rna
synthesi
enhanc
csfv
rnadepend
rna
polymeras
activ
viru
speciesspecif
manner
studi
indic
residu
core
protein
requir
enhanc
activ
csfv
replicationassoci
protein
howev
protein
also
play
import
role
intern
ribosom
entri
site
ire
mediat
translat
csfv
csfv
multifunct
protein
possess
serin
proteas
rna
helicas
nucleosid
triphosphatas
ntpase
activ
rna
helicas
activ
could
promot
viral
cellular
translat
wherea
proteas
domain
interact
enhanc
viral
translat
contrast
protein
inhibitori
effect
iresmedi
translat
protein
suppress
inhibitori
effect
viral
translat
bind
residu
locat
ctermin
half
amino
acid
aa
aa
highli
conserv
gdd
motif
necessari
interact
furthermor
termin
sequenc
harbor
posit
neg
regulatori
element
control
iresmedi
translat
csfv
neg
cisact
element
hexam
cggccc
sequenc
moreov
mutat
within
ire
affect
translat
initi
effici
csfv
npro
csfv
involv
viru
rna
translat
cytoplasm
also
counteract
doublestrand
rnamedi
apoptosi
induct
studi
elucid
interferon
synthesi
prevent
inhibit
transcript
promot
degrad
interferon
regulatori
factor
via
zincbind
abil
viral
npro
npro
also
redistribut
mitochondria
peroxisom
inactiv
inhibit
apoptosi
addit
npro
influenc
innat
immun
respons
local
site
viru
replic
pig
contribut
pathogen
viral
replic
csfv
use
report
system
denv
demonstr
utr
essenti
viral
rna
replic
translat
rna
replic
denv
requir
rnarnamedi
circular
viral
genom
utr
form
sever
addit
rna
element
involv
regul
translat
rna
replic
first
nt
utr
compris
variabl
region
vr
could
divid
hypervari
region
hvr
semivari
region
svr
vr
import
denv
replic
associ
accumul
denv
rna
mammalian
cell
core
region
denv
rna
form
two
dumbbel
structur
four
pseudoknot
requir
rna
replic
also
optim
translat
protein
contain
ntermin
serin
proteas
region
join
rna
helicas
acid
linker
linker
region
confer
flexibl
protein
requir
polyprotein
process
rna
replic
furthermor
host
factor
interact
utr
facilit
viral
rna
replic
two
nlss
within
central
region
anl
bnl
recogn
importin
importin
nuclear
transport
respect
lead
nuclear
accumul
moreov
heterogen
ribonucleoprotein
hnrnp
interact
particip
viral
rna
synthesi
viral
assembl
matur
capsid
protein
denv
accumul
surfac
erderiv
lipid
droplet
cytoplasm
addit
denv
induc
low
level
interferon
regulatori
factor
activ
block
tlrtrigger
activ
thu
lead
reduc
cytokin
product
addit
dynam
denv
infect
mice
reveal
viru
local
predominantli
lymphoid
gutassoci
tissu
cellbas
report
system
also
repres
rapid
low
cost
high
throughput
assay
antivir
agent
antibodi
evalu
replicon
system
use
antivir
drug
develop
mani
antihcv
compound
target
screen
use
hcv
replicon
system
avail
sustain
virolog
respons
major
patient
recent
pan
colleagu
develop
proteasebas
report
assay
suitabl
effici
assess
hcv
infect
also
use
high
throughput
screen
antihcv
agent
system
viru
replicationinfect
cell
could
quantit
indic
measur
seap
activ
cell
cultur
medium
similarli
dual
report
system
wnv
base
subgenom
replicon
encod
rluc
neomycin
phosphotransferas
gener
incub
report
cell
known
wnv
inhibitor
decreas
luciferas
activ
well
replicon
rna
level
efficaci
inhibitor
measur
depress
luciferas
activ
report
cell
compar
deriv
authent
viral
infect
assay
indic
report
cell
line
use
high
throughput
assay
antiwnv
drug
denv
anoth
sever
mosquitoborn
viral
pathogen
neither
vaccin
antivir
therapi
current
avail
treat
diseas
use
cellbas
report
system
sever
compound
identifi
potenti
antivir
agent
two
novel
flavon
pmf
tmf
discov
denvinhibitori
properti
one
effect
compound
smallmolecul
chemic
found
suppress
viral
rna
replic
doxorubicin
deriv
inhibit
denv
replic
earli
stage
viral
replic
cycl
furthermor
nucleosid
inhibitor
target
viral
polymeras
prove
promis
develop
drug
virus
report
nucleosid
analog
exert
specif
antidenv
rna
polymeras
activ
denv
subgenom
rna
replicon
infecti
system
well
suckl
mice
model
inhibitori
concentr
valu
moreov
identifi
smallmolecul
inhibitor
denv
proteas
use
stabl
cell
line
harbor
effici
luciferas
replicon
denv
studi
elucid
inhibit
replic
viral
rna
synthesi
interact
central
hydrophil
portion
cofactor
target
proteas
addit
new
compound
discov
proteas
inhibitor
valu
rang
compound
belong
two
differ
scaffold
activ
extent
denv
base
luciferas
report
repliconbas
assay
addit
amodiaquin
aq
inhibit
infect
valu
respect
inhibit
viral
rna
replic
valu
repliconexpress
cell
phydroxyanilino
diethylaminomethyl
moieti
import
aq
inhibit
replic
infect
context
viru
diseas
control
reliabl
high
throughput
tool
antibodi
vaccin
evalu
also
import
allow
understand
impact
neutral
antibodi
diseas
progress
vaccin
efficaci
viru
report
system
emerg
promis
strategi
antibodi
vaccin
evalu
report
system
use
denv
rvp
use
measur
neutral
antibodi
human
serum
sampl
four
denv
serotyp
result
show
denv
rvp
yield
serotypespecif
respons
reproduc
neutral
titer
statist
agreement
plaqu
reduct
neutral
test
prnt
result
similarli
stabl
rluc
report
system
denv
lucdenv
develop
measur
neutral
antibodydepend
enhanc
activ
luciferas
valu
analysi
use
variou
known
denvspecif
monoclon
antibodi
clinic
sampl
infect
anim
individu
show
good
repeat
linear
correl
convent
plaquebas
assay
addit
rapid
system
produc
chimer
singleround
infecti
particl
srip
flavivirus
develop
use
japanes
enceph
viru
subgenom
replicon
plasmid
srip
evalu
antigen
function
antibodi
assay
result
signific
correl
shown
antibodi
titer
obtain
use
srip
obtain
use
antigen
indic
srip
use
altern
antigen
function
antibodi
assay
vrpbase
neutral
assay
chikv
infect
establish
use
gluc
readout
vrp
could
produc
effici
cell
cotransfect
chikv
replicon
express
gluc
helper
rna
subsequ
infect
vrp
measur
via
gluc
secret
supernat
chikvneutr
antibodi
could
determin
within
day
assay
without
need
use
infecti
chikv
cellbas
report
system
also
well
suit
use
clinic
examin
epidemiolog
surveil
subgenom
report
rna
system
develop
steel
colleagu
rel
speci
specif
allow
rapid
simpl
visual
detect
wildtyp
virus
mosquito
cell
moreov
replicondefect
report
gene
assay
could
detect
varieti
alphavirus
tissu
cultur
limit
detect
one
ten
plaqueform
unit
pfu
sinv
rna
virus
japanes
enceph
viru
tahyna
viru
display
neg
result
system
cellbas
report
system
enhanc
understand
molecular
mechan
viru
replic
pathogenesi
well
viru
interact
host
cell
also
provid
platform
viru
detect
drug
suscept
test
tabl
howev
still
sever
issu
system
need
explor
first
positivesens
singl
strand
virus
success
cellbas
report
system
one
futur
challeng
gener
sensit
cellbas
report
system
detect
track
emerg
virus
pathogen
virus
current
cultiv
second
virus
highli
variabl
undergo
frequent
mutat
new
report
system
virus
need
develop
identifi
mutat
serotyp
effici
accur
addit
futur
challeng
lie
optim
cellbas
report
system
high
throughput
screen
antivir
agent
